Cystic Fibrosis Trial, Recruiting NCT05501587 Sponsor: University of British Columbia Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT05501587
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with cystic fibrosis (CF), shown either by a sweat test result of 60 or above, or by having two CF-causing gene changes identified through genetic testing
  • You have been diagnosed with another type of lung disease by a doctor
  • You are a healthy person with no known lung disease
  • You or your parent/legal guardian are able to give consent to take part
  • In the study doctor's opinion, you are likely to be able to complete the breathing test on the day it is scheduled

Who may not be able to join:

  • You have physical signs at your initial check-up that could put your safety at risk or affect the quality of the study results (for example, you are having significant difficulty breathing)
  • You need extra oxygen to keep your blood oxygen levels above 95%
  • You are a healthy volunteer but show signs of having a lung disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jonathan Rayment, MDCM, MSc, University of British Columbia

Phone: 6048752345

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 October 2018
Est. completion
1 May 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

To validate new lung function testing technologies

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov